Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo

Bibliographic Details
Main Authors:	Yu-Yin Xu, Li Chen, Gui-Lan Wang, Jia-Ming Zhou, Yi-Xin Zhang, Yin-Ze Wei, Yuan-Yuan Zhu, Jing Qin
Format:	Article
Language:	English
Published:	BMC 2023-07-01
Series:	BMC Cancer
Online Access:	https://doi.org/10.1186/s12885-023-11135-3

Internet